Literature DB >> 9155945

Non-dermatophytes in onychomycosis of the toenails.

D H Ellis1, A B Watson, J E Marley, T G Williams.   

Abstract

A multicentre trial for the treatment of dermatophyte onychomycosis of the toenails with terbinafine was carried out in Australia and New Zealand. Between eight and 12 nail samples were obtained from each of the 118 patients in the 48-week trial, and each sample was investigated by direct microscopy and culture for dermatophyte and non-dermatophyte fungi. Patients were randomized to treatment with terbinafine at 250 mg/day or placebo for the first 12 weeks of the study, then non-responders were offered a 12-week course of terbinafine from week 28. All patients had a dermatophyte infection. In 42 patients (36%) microscopy and mycological culture identified dermatophytes alone. In the remaining 76 patients (64%), a non-dermatophyte mould or yeast was also isolated at some stage during the trial, but in only three patients did the same non-dermatophyte persist in two or more successive nail specimens. The presence of a fungal contaminant in addition to a dermatophyte had no apparent effect on the efficacy of treatment with terbinafine. We conclude that non-dermatophyte moulds and yeasts are generally found as contaminating organisms in dermatophyte onychomycosis, secondary to the dermatophytes, and that they do not influence the outcome of treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155945

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  22 in total

1.  Skin and nail fungi-almost beaten.

Authors:  A Y Finlay
Journal:  BMJ       Date:  1999-07-10

2.  Nattrassia mangiferae: An uncommon agent of onychomycosis.

Authors:  Partha Roy; Puneet Bhatt
Journal:  Med J Armed Forces India       Date:  2013-11-20

3.  Epidemiology of onychomycosis and paronychia in the area of ANCONA (ITALY) over a period of 5 years.

Authors:  O Simonetti; M L Bernardini; D Arzeni; A Cellini; F Barchiesi; A Offidani
Journal:  Mycopathologia       Date:  2004-10       Impact factor: 2.574

Review 4.  Oral antifungal medication for toenail onychomycosis.

Authors:  Sanne Kreijkamp-Kaspers; Kate Hawke; Linda Guo; George Kerin; Sally Em Bell-Syer; Parker Magin; Sophie V Bell-Syer; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2017-07-14

Review 5.  Allergy and dermatophytes.

Authors:  Judith A Woodfolk
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  Non-dermatophytic molds as agents of onychomycosis in Izmir, Turkey - a prospective study.

Authors:  S Hilmioğlu-Polat; D Y Metin; R Inci; T Dereli; I Kilinç; E Tümbay
Journal:  Mycopathologia       Date:  2005-09       Impact factor: 2.574

Review 7.  Which antifungal agent for onychomycosis? A pharmacoeconomic analysis.

Authors:  V N Joish; E P Armstrong
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

8.  Onychomycosis due to Neoscytalidium treated with oral terbinafine, ciclopirox nail lacquer and nail abrasion: a pilot study of 25 patients.

Authors:  Ígor B Cursi; Roberta Teixeira Silva; Isabella Brasil Succi; Andréa R Bernardes-Engemann; Rosane Orofino-Costa
Journal:  Mycopathologia       Date:  2012-09-14       Impact factor: 2.574

9.  Emerging fungal infections among children: A review on its clinical manifestations, diagnosis, and prevention.

Authors:  Akansha Jain; Shubham Jain; Swati Rawat
Journal:  J Pharm Bioallied Sci       Date:  2010-10

10.  Application of polymerase chain reaction (PCR) and PCR based restriction fragment length polymorphism for detection and identification of dermatophytes from dermatological specimens.

Authors:  R Bagyalakshmi; B Senthilvelan; K L Therese; S Murugusundram; H N Madhavan
Journal:  Indian J Dermatol       Date:  2008-01       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.